2022 AUGUST 23 (NewsRx) — By One News Reporter – Staff News Editor at China Daily News — New cancer research is reported. According to reports from NankeenPeople Republic of Chinaby NewsRx reporters, the research said, “In order to establish a long-term strategy to bear the costs of cancer drugs, the state had held five rounds of price negotiations at the national level and introduced the coverage of national health insurance (NHIC) policy since 2016. In addition, the National Healthcare Security Administration (NHSA) has introduced the Volume Based Purchase (VBP) pilot program to Nankeen in September 2019.
Funders of this research include National Natural Science Foundation of China, Chinese Medical Council.
News correspondents got a quote from the research of the Nanjing Medical University Clinical College, “Taking the example of non-small cell lung cancer, the objective of the study was to test whether national tariff negotiations, NHIC policy and the VBP pilot program had a positive impact on the accessibility of three targeted cancer drugs. Based on hospital supply data, an interrupted time series (ITS) model was used to analyze the effect of health policy on the accessibility and affordability of gefitinib, bevacizumab and recombinant human endostatin from January 2013 at December 2020 in Nankeen, China. The DDDs of all three drugs increased significantly after policy implementation (
According to the journalists, the research concluded: “Additional multi-pronged measures and policy approaches by multiple stakeholders will facilitate equitable access to effective and affordable cancer drugs.
For more information on this research, see: Trends in Accessibility of Targeted Cancer Drugs Brokered in Nankeen, China: An analysis of interrupted time series. Frontiers in public health2022;10:942638. Frontiers in public health can be contacted at: Frontiers Media Sa, Avenue Du Tribunal Fédéral 34, Lausanne, Ch-1015, Swiss.
Our journalists inform that additional information can be obtained by contacting Huining Yi, Nanjing Drum Tower Hospital, Nanjing Medical University Clinical College, NankeenPeople Republic of China. Other authors of this research include Yanyan Liu, Kexin Fang, Yuwen Bao and Xin Li.
The direct object identifier (DOI) for this additional information is: https://doi.org/10.3389/fpubh.2022.942638. This DOI is a link to a free or paid online electronic document, and can be your direct source for a journal article and its citation.
Journal editor contact details Frontiers in public health is: Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Swiss.
(Our reports provide factual information on research and discoveries from around the world.)